Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Acute hepatitis E in French patients and neurological manifestations.

Abravanel F, Pique J, Couturier E, Nicot F, Dimeglio C, Lhomme S, Chiabrando J, Saune K, Péron JM, Kamar N, Evrard S, de Valk H, Cintas P, Izopet J; HEV study group.

J Infect. 2018 Sep;77(3):220-226. doi: 10.1016/j.jinf.2018.06.007. Epub 2018 Jul 10.

PMID:
29966614
2.

A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces.

Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Boineau J, Sauné K, Izopet J.

J Clin Virol. 2018 Aug;105:109-111. doi: 10.1016/j.jcv.2018.06.013. Epub 2018 Jun 22.

PMID:
29957544
3.

Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.

Nicot F, Jeanne N, Raymond S, Delfour O, Carcenac R, Lefebvre C, Sauné K, Delobel P, Izopet J.

J Med Virol. 2018 Sep;90(9):1486-1492. doi: 10.1002/jmv.25224. Epub 2018 May 25.

PMID:
29750364
4.

Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.

Pol S, Marion O, Vallet-Pichard A, Meritet JF, Sauné K, Alric L, Kamar N.

Transpl Infect Dis. 2018 Jun;20(3):e12864. doi: 10.1111/tid.12864. Epub 2018 Mar 25.

PMID:
29512231
5.

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.

Raymond S, Nicot F, Carcenac R, Lefebvre C, Jeanne N, Saune K, Delobel P, Izopet J.

J Antimicrob Chemother. 2018 May 1;73(5):1152-1157. doi: 10.1093/jac/dky003.

PMID:
29444253
6.

A European multicenter study on the analytical performance of the VERIS HBV assay.

Braun P, Delgado R, Drago M, Fanti D, Fleury H, Izopet J, Lombardi A, Mancon A, Marcos MA, Sauné K, O Shea S, Pérez-Rivilla A, Ramble J, Trimoulet P, Vila J, Whittaker D, Artus A, Rhodes D.

J Clin Virol. 2018 Feb - Mar;99-100:50-56. doi: 10.1016/j.jcv.2017.12.009. Epub 2017 Dec 19.

PMID:
29328964
7.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.

Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group.

Clin Infect Dis. 2018 May 2;66(10):1588-1594. doi: 10.1093/cid/cix1070.

PMID:
29244143
8.

Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.

Pasquier C, Walschaerts M, Raymond S, Moinard N, Saune K, Daudin M, Izopet J, Bujan L.

Basic Clin Androl. 2017 Sep 8;27:17. doi: 10.1186/s12610-017-0063-x. eCollection 2017.

9.

A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit.

Braun P, Delgado R, Drago M, Fanti D, Fleury H, Izopet J, Lombardi A, Marcos M, Sauné K, O'Shea S, Pérez-Rivilla A, Ramble J, Trimoulet P, Vila J, Whittaker D, Artus A, Rhodes D.

J Clin Virol. 2017 Oct;95:76-83. doi: 10.1016/j.jcv.2017.08.015. Epub 2017 Sep 9.

PMID:
28892764
10.

Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.

Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V; ANRS-AC11 Quantification Working Group.

J Med Virol. 2017 Nov;89(11):2047-2050. doi: 10.1002/jmv.24874. Epub 2017 Jul 6.

PMID:
28617961
11.

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay.

Braun P, Delgado R, Drago M, Fanti D, Fleury H, Hofmann J, Izopet J, Kühn S, Lombardi A, Mancon A, Marcos MA, Mileto D, Sauné K, O'Shea S, Pérez-Rivilla A, Ramble J, Trimoulet P, Vila J, Whittaker D, Artus A, Rhodes D.

J Clin Virol. 2017 Jul;92:75-82. doi: 10.1016/j.jcv.2017.05.003. Epub 2017 May 11.

PMID:
28599228
12.

Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study.

Dörr G, Del Bello A, Abravanel F, Marion O, Cointault O, Ribes D, Lavayssière L, Esposito L, Nogier MB, Hebral AL, Sauné K, Izopet J, Kamar N.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12725. Epub 2017 Jun 26.

PMID:
28509330
13.

European Multicenter Study on Analytical Performance of Veris HIV-1 Assay.

Braun P, Delgado R, Drago M, Fanti D, Fleury H, Hofmann J, Izopet J, Kalus U, Lombardi A, Marcos MA, Mileto D, Sauné K, O'Shea S, Pérez-Rivilla A, Ramble J, Trimoulet P, Vila J, Whittaker D, Artus A, Rhodes DW.

J Clin Microbiol. 2017 Jul;55(7):2055-2063. doi: 10.1128/JCM.00078-17. Epub 2017 Apr 19.

14.

Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus.

Pasquier C, Sauné K, Raymond S, Boisneau J, Courtade M, Izopet J.

Diagn Microbiol Infect Dis. 2017 Jan;87(1):25-27. doi: 10.1016/j.diagmicrobio.2016.08.022. Epub 2016 Aug 28.

PMID:
28336133
15.

A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay.

Braun P, Drago M, Fanti D, Fleury H, Hofmann J, Izopet J, Kühn S, Lombardi A, Micheli V, Sauné K, Trimoulet P, Whittaker D, Artus A, Rhodes D.

J Clin Virol. 2017 May;90:18-25. doi: 10.1016/j.jcv.2017.03.006. Epub 2017 Mar 9.

PMID:
28319847
16.

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use.

Raymond S, Nicot F, Jeanne N, Delfour O, Carcenac R, Lefebvre C, Cazabat M, Sauné K, Delobel P, Izopet J.

Sci Rep. 2017 Feb 10;7:42215. doi: 10.1038/srep42215.

17.

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay.

Braun P, Delgado R, Drago M, Fanti D, Fleury H, Gismondo MR, Hofmann J, Izopet J, Kühn S, Lombardi A, Marcos MA, Sauné K, O'Shea S, Pérez-Rivilla A, Ramble J, Trimoulet P, Vila J, Whittaker D, Artus A, Rhodes DW.

J Clin Microbiol. 2017 Apr;55(4):1186-1192. doi: 10.1128/JCM.02163-16. Epub 2017 Feb 1.

18.

HEV infection in French HIV-infected patients.

Abravanel F, Lhomme S, Fougère M, Saune K, Alvarez M, Péron JM, Delobel P, Izopet J.

J Infect. 2017 Mar;74(3):310-313. doi: 10.1016/j.jinf.2016.12.004. Epub 2016 Dec 18.

PMID:
27998748
19.

Detection and quantification of HIV-1 RNA with a fully automated transcription-mediated-amplification assay.

Sauné K, Raymond S, Boineau J, Pasquier C, Izopet J.

J Clin Virol. 2016 Nov;84:70-73. doi: 10.1016/j.jcv.2016.09.002. Epub 2016 Oct 5.

PMID:
27728849
20.

Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.

Sauné K, Abravanel F, Haslé C, Boineau J, Mengelle C, Izopet J.

J Clin Virol. 2016 Nov;84:7-11. doi: 10.1016/j.jcv.2016.09.003. Epub 2016 Sep 13.

PMID:
27636506
21.

Quantification of HEV RNA by Droplet Digital PCR.

Nicot F, Cazabat M, Lhomme S, Marion O, Sauné K, Chiabrando J, Dubois M, Kamar N, Abravanel F, Izopet J.

Viruses. 2016 Aug 19;8(8). pii: E233. doi: 10.3390/v8080233.

22.

A nationwide survey of hepatitis E viral infection in French blood donors.

Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, Morel P, Legrand D, Tiberghien P, Izopet J.

Hepatology. 2016 Apr;63(4):1145-54. doi: 10.1002/hep.28436. Epub 2016 Feb 26.

PMID:
27008201
23.

Brief Report: HIV-1 Tropism During Primary Infections in France: 1996-2014.

Raymond S, Nicot F, Sauné K, Cazabat M, Pasquier C, Massip P, Marchou B, Delobel P, Izopet J.

J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):376-9. doi: 10.1097/QAI.0000000000000984.

PMID:
26959188
24.

Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients.

Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J, Champagne E.

J Infect. 2016 Jun;72(6):723-730. doi: 10.1016/j.jinf.2016.02.016. Epub 2016 Mar 4.

PMID:
26947133
25.

Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.

Lhomme S, Kamar N, Nicot F, Ducos J, Bismuth M, Garrigue V, Petitjean-Lecherbonnier J, Ollivier I, Alessandri-Gradt E, Goria O, Barth H, Perrin P, Saune K, Dubois M, Carcenac R, Lefebvre C, Jeanne N, Abravanel F, Izopet J.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1608-14. doi: 10.1128/AAC.02496-15.

26.

Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced Men.

Gagneux-Brunon A, Nasri D, Terrasse R, Sauné K, Gagnieu MC, Frésard A, Delezay O, Izopet J, Pozzetto B, Lucht F, Bourlet T.

Curr HIV Res. 2016;14(4):316-23.

PMID:
26577801
27.

Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.

Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M; Dat’AIDS study group.

AIDS. 2015 Aug 24;29(13):1665-71. doi: 10.1097/QAD.0000000000000723.

PMID:
26372277
28.

Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.

Izopet J, Labrique AB, Basnyat B, Dalton HR, Kmush B, Heaney CD, Nelson KE, Ahmed ZB, Zaman K, Mansuy JM, Bendall R, Sauné K, Kamar N, Arjyal A, Karkey A, Dongol S, Prajapati KG, Adhikary D.

J Clin Virol. 2015 Sep;70:39-42. doi: 10.1016/j.jcv.2015.06.103. Epub 2015 Jun 29.

PMID:
26305817
29.

An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.

Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I, Del Bello A, Dörr G, Lavayssière L, Nogier MB, Guitard J, Ribes D, Goin AL, Broué P, Metsu D, Sauné K, Rostaing L, Izopet J.

Transplantation. 2015 Oct;99(10):2124-31. doi: 10.1097/TP.0000000000000850.

PMID:
26214817
30.

Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.

Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, L Homme S, Destruel F, Kamar N, Izopet J.

Euro Surveill. 2015 May 14;20(19):27-34.

31.

Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.

Nicot F, Sauné K, Raymond S, Jeanne N, Carcenac R, Lefebvre C, Cuzin L, Marchou B, Delobel P, Izopet J.

J Clin Virol. 2015 Jan;62:20-4. doi: 10.1016/j.jcv.2014.10.020. Epub 2014 Nov 20.

PMID:
25542465
32.

Hepatitis E virus infections in blood donors, France.

Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F, Assal A, Tiberghien P, Izopet J.

Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.

33.

The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit.

Mengelle C, Mansuy JM, Pierre A, Claudet I, Grouteau E, Micheau P, Sauné K, Izopet J.

J Clin Virol. 2014 Nov;61(3):411-7. doi: 10.1016/j.jcv.2014.08.023. Epub 2014 Sep 3.

PMID:
25223920
34.

Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.

Raymond S, Saliou A, Delobel P, Cazabat M, Pasquier C, Jeanne N, Sauné K, Massip P, Marchou B, Izopet J.

J Antimicrob Chemother. 2014 Sep;69(9):2527-30. doi: 10.1093/jac/dku147. Epub 2014 May 19.

PMID:
24840625
35.

Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients.

Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J.

J Infect Dis. 2014 Jan 15;209(2):300-3. doi: 10.1093/infdis/jit438. Epub 2013 Aug 20.

PMID:
23964111
36.

Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.

Raymond S, Saliou A, Nicot F, Delobel P, Dubois M, Carcenac R, Sauné K, Marchou B, Massip P, Izopet J.

J Antimicrob Chemother. 2013 Dec;68(12):2875-81. doi: 10.1093/jac/dkt290. Epub 2013 Jul 18.

PMID:
23869053
37.

An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy.

Pugliese P, Delpierre C, Cuzin L, Poizot-Martin I, Rey D, Saune K, Cottalorda J, Bettinger D, Delaugerre C, Hoen B; Dat AIDS Study Group.

HIV Med. 2013 Sep;14(8):509-15. doi: 10.1111/hiv.12041. Epub 2013 May 8.

38.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.

Thibault V, Gaudy-Graffin C, Colson P, Gozlan J, Schnepf N, Trimoulet P, Pallier C, Saune K, Branger M, Coste M, Thoraval FR; ANRS Multivir-HBV group.

Virol J. 2013 Mar 15;10:87. doi: 10.1186/1743-422X-10-87.

39.

Analytical sensitivity of three real-time PCR assays for measuring subtype B HIV-1 RNA.

Sauné K, Delaugerre C, Raymond S, Nicot F, Boineau J, Pasquier C, Izopet J.

J Clin Virol. 2013 May;57(1):80-3. doi: 10.1016/j.jcv.2012.12.017. Epub 2013 Jan 11.

PMID:
23317874
40.

Hepatitis B screening: who to target? A French sexually transmitted infection clinic experience.

Spenatto N, Boulinguez S, Mularczyk M, Molinier L, Bureau C, Saune K, Viraben R.

J Hepatol. 2013 Apr;58(4):690-7. doi: 10.1016/j.jhep.2012.11.044. Epub 2012 Dec 5.

PMID:
23220369
41.

Performance of a rapid molecular multiplex assay for the detection of influenza and picornaviruses.

Mansuy JM, Mengelle C, Da Silva I, Grog I, Sauné K, Izopet J.

Scand J Infect Dis. 2012 Dec;44(12):963-8. doi: 10.3109/00365548.2012.704150. Epub 2012 Jul 25.

PMID:
22830610
42.

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

Nicot F, Saliou A, Raymond S, Sauné K, Dubois M, Massip P, Marchou B, Delobel P, Izopet J.

J Clin Virol. 2012 Oct;55(2):107-13. doi: 10.1016/j.jcv.2012.06.018. Epub 2012 Jul 20.

PMID:
22818969
43.

Factors associated with a strictly undetectable viral load in HIV-1-infected patients.

Martin-Blondel G, Sauné K, Vu Hai V, Marchou B, Delobel P, Izopet J, Cuzin L, Massip P.

HIV Med. 2012 Oct;13(9):568-73. doi: 10.1111/j.1468-1293.2012.01012.x. Epub 2012 Mar 21.

44.

Antiviral effect of maraviroc in semen: a case report.

Pasquier C, Moinard N, Sauné K, Daudin M, Trancart S, Massip P, Izopet J, Bujan L.

Antivir Ther. 2012;17(5):933-6. doi: 10.3851/IMP2038. Epub 2012 Feb 1.

PMID:
22297568
45.

A new highly automated extraction system for quantitative real-time PCRs from whole blood samples: routine monitoring of opportunistic infections in immunosuppressed patients.

Mengelle C, Mansuy JM, Sauné K, Barthe C, Boineau J, Izopet J.

J Clin Virol. 2012 Apr;53(4):314-9. doi: 10.1016/j.jcv.2012.01.002. Epub 2012 Jan 30.

PMID:
22296792
46.

Hepatitis E virus antibodies in blood donors, France.

Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J.

Emerg Infect Dis. 2011 Dec;17(12):2309-12. doi: 10.3201/eid1712.110371.

47.

Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.

Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N.

Transplantation. 2011 Apr 27;91(8):916-20. doi: 10.1097/TP.0b013e3182100f59.

PMID:
21325995
48.

Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.

Nicot F, Alric L, Barange K, Métivier S, Dramard JM, Combis JM, Castan B, Meurisse JJ, Payen JL, Garipuy D, Desmorat H, Peron JM, Thebault S, Morin T, Renou C, Barel P, Guerin B, Imbert Y, Sire S, Sauné K, Chatelut E, Izopet J.

J Med Virol. 2011 Mar;83(3):437-44. doi: 10.1002/jmv.21976.

PMID:
21264864
49.

Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.

Sauné K, Kamar N, Miédougé M, Weclawiak H, Dubois M, Izopet J, Rostaing L.

Nephrol Dial Transplant. 2011 Jul;26(7):2309-16. doi: 10.1093/ndt/gfq696. Epub 2010 Nov 19.

PMID:
21097646
50.

Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients.

Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J.

J Clin Virol. 2010 May;48(1):18-21. doi: 10.1016/j.jcv.2010.02.012. Epub 2010 Mar 15.

PMID:
20233674

Supplemental Content

Support Center